Read the rest here: Shockwave Medical to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Read the rest here: Shockwave Medical to Participate in the 23rd Annual Needham Virtual Healthcare Conference
More here: Entera Bio Announces Key Regulatory Milestone for Oral PTH(1-34) Peptide (EB613) Phase 3 Program: FDA Ruling on Qualifying BMD as a Surrogate Endpoint...
Follow this link: ABVC BioPharma Entered into a Global Licensing Deal of Vitargus with Licensing Income of $33.5M and Royalties up to $60M
Read more: PharmAla Biotech Signs Sale Agreement with Numinus
The rest is here: Inozyme Pharma to Report Topline Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ABCC6 Deficiency and ENPP1 Deficiency on April 8, 2024
The rest is here: AIM ImmunoTech to Discuss Fourth Quarter and Full Year 2023 Financial Results on April 2, 2024, and Host Conference Call and Webcast
Excerpt from: Celularity Receives Healthcare Common Procedure Coding System (HCPCS) Q Code Approval from the U.S. Centers for Medicare & Medicaid Services for...
See original here: Alterity Therapeutics Receives a A$3.9 Million Research & Development Tax Incentive Refund
Original post: Better Choice Company Initiates Legal Action Against Alphia, a Portfolio Company of Private Equity Firm PAI
Recent Comments